Original ArticleEvaluation of baseline contractile reserve vs dyssynchrony as a predictor of functional improvement and long term outcome after resynchronization pacing therapy: A radionuclide stress study
Introduction
Cardiac resynchronization therapy (CRT) has emerged as an adjunctive treatment option in patients with drug-refractory heart failure. Current guidelines indicate as candidates to CRT the patients with low left ventricular ejection fraction (LVEF ≤35%), advanced heart failure (NYHA functional class III or IV) and prolonged QRS duration (>130 ms).1,2 However, with the use of these criteria, approximately 30% of patients fail to improve clinical symptoms and 40%-50% show no improvement in LV function.3., 4., 5., 6., 7., 8., 9.
Therefore, considering the potential for a greatly expanded patient population with heart failure undergoing CRT and the cost of the treatment, interest has been shifted toward more accurate criteria of selection and identification of potential responders to therapy before pacemaker implantation.10 It has been recognized that the effect of CRT is likely modulated by multiple factors including baseline left ventricular function and extent of ventricular dyssynchrony, correct lead positioning and pacing, but also the extent of myocardial fibrosis and tissue viability as estimated by measurement of myocardial contractile reserve (mCR).11., 12., 13., 14., 15.
Several cardiac imaging modalities have been proposed to evaluate ventricular function and dyssynchrony of contraction including M-Mode, bi-dimensional, and tissue Doppler imaging of trans-thoracic echocardiography16., 17., 18. and nuclear imaging techniques with phase analysis of either ecg-gated equilibrium radionuclide angiography (ERNA)19., 20., 21., 22. or SPECT myocardial perfusion imaging.23
Among several methods to unmask viable and recruitable myocardium in the failing heart, low-dose dobutamine (LDD) stress testing in association with either cardiac echocardiographic or radionuclide imaging has gained recognition as an important and accurate modality to predict functional improvement after interventions.24., 25., 26.
The aim of this study was to prospectively evaluate whether simultaneous assessment of baseline ventricular dyssynchrony, wall motion abnormalities and mCR by ERNA and LDD stress testing may help identifying responders to treatment.
Section snippets
Patients and Study Design
We studied 57 patients (47 male and 10 female; age 73.5 ± 7.5 years) with drug-refractory heart failure, fulfilling current indication criteria for CRT. Patients with permanent atrial fibrillation were excluded. Twenty-one patients with sustained or non-sustained ventricular tachyarrhythmias requiring cardiac resynchronization-defibrillator device were included. The clinical characteristics of patients groups are shown in Table 1.
All patients underwent baseline ERNA with parametric phase
Effect of CRT on Dyssynchrony and Left Ventricular Function
At baseline, most candidates for CRT (85%) had evidence of intra-ventricular dyssynchrony (Table 1) but there was a weak correlation between intra-ventricular dyssynchrony and LVEF (r = 0.38) (Figure 2). No correlation was found between inter-ventricular dyssynchrony and LVEF (r = 0.17) or baseline QRS duration (r = 0.18).
The effect of CRT was examined in 53 patients who completed the pre-implant and post-CRT evaluation. Four patients were excluded from further analysis after attempted
Discussion
Several large clinical trials have been conducted to assess the functional changes and clinical outcome after CRT. These studies have shown improvement in functional status, quality of life, exercise capacity, and left ventricular function in CRT patients as compared to controls.3., 4., 5., 6., 7., 8., 9. However, placebo effect in CRT patients has been described in about 40% of pacing-off CRT patients in Miracle trial.5 Only two studies have reported a decrease in the risk of death and
Acknowledgments
We are indebted to Luca Ceriani MD (Lugano, Switzerland) for its strong and skilled work in the evaluation of the first nuclear studies. We are also grateful to Rocco Lucianini (Varese, Italy) for its help in data processing and image analysis, to Laura Gaiara MD for data collection and to Claudio Marcassa, MD (Veruno, Italy) and Roberto De Ponti, MD (Varese, Italy) for their friendly help in reviewing the manuscript.
References (33)
- et al.
ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices
J Am Coll Cardiol
(2002) - et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The task force for cardiac pacing and cardiac resynchronisation therapy of the European Society of Cardiology
Eur Heart J
(2007) - et al.
Cardiac Resynchronisation-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure
N Engl J Med
(2005) - et al.
Long term benefit of biventricular pacing in congestive heart failure: Results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) study
J Am Coll Cardiol
(2002) - et al.
Cardiac resynchronization in chronic heart failure
N Engl J Med
(2002) - et al.
The COMPANION Investigators Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
N Engl J Med
(2004) - et al.
Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials
JAMA
(2003) - et al.
Systematic review: Cardiac resynchronization in patients with symptomatic heart failure
Ann Intern Med
(2004) - et al.
Clinical comparison and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the multicenter InSync randomized clinical evaluation (MIRACLE) and multicenter In Sync ICD randomised clinical evaluation (MIRACLE-ICD) trials
Am Heart J
(2006) - et al.
Selecting patients for cardiac resynchronization therapy: Electrical or mechanical dyssynchrony?
Eur Heart J
(2006)
Effect of postero-lateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy
Circulation
Importance of contractile reserve for CRT
Europace
Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders
Heart Rhythm
Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy
Am Heart J
Impact of contractile reserve on acute response to cardiac resynchronization therapy
Cardiovasc Ultrasound
Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy
J Am Coll Cardiol
Cited by (7)
Does presence of left ventricular contractile reserve improve response to cardiac resynchronization therapy? An updated meta-analysis
2018, International Journal of CardiologyDyssynchronous! remediable?
2012, Journal of Nuclear CardiologyLow-dose dobutamine stress gated blood pool SPECT assessment of left ventricular contractile reserve in ischemic cardiomyopathy: a feasibility study
2022, European Journal of Nuclear Medicine and Molecular ImagingPerspective and future direction of intraventricular mechanical dyssynchrony assessment
2021, Journal of Nuclear CardiologyNuclear Cardiology for the Prediction of Response to Cardiac Resynchronization Therapy
2017, Current Cardiovascular Imaging Reports